Heromin Ronald John is categorized under Orthopedic Doctors and Physicians in Englewood, FL and active since 1987.
Heromin Ronald John was established in 1987, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Ronald J Heromin at the company’s single location by writing to 779 Medical Drive # 7, Englewood, Florida FL 34223 or by phoning (941) 475-5626. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Heromin Ronald John |
| Contact Person: | Ronald J Heromin |
| Address: | 779 Medical Drive # 7, Englewood, Florida 34223 |
| Phone Number: | (941) 475-5626 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1987 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Orthopedic Doctors and Physicians |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Heromin Ronald John was started in 1987 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Ronald J Heromin for inquiries that concern Heromin Ronald John by calling the company number (941) 475-5626, as your correspondence is most welcome. Additionally, the physical location of the single location of Heromin Ronald John can be found at the coordinates 26.949795,-82.325232 as well as the street address 779 Medical Drive # 7 in Englewood, Florida 34223.
For its online presence, you may visit Heromin Ronald John’s website at and engage with its social media outlets through on Twitter and on Facebook.